Li Hui Chang

Director of Finance/CFO bei FORMOSA OPTICAL TECHNOLOGY CO.,LTD.

Health Technology

Process Industries

Consumer Services

Profil

Li Hui Chang is currently working as a Director at Polylite Taiwan Co. Ltd., a Director at Essilor Amera Pte Ltd., and as the Vice President-Finance & Accounting Office at Formosa Optical Technology Co., Ltd.
Mr. Chang completed their undergraduate degree at Fu Jen Catholic University.

Aktive Positionen von Li Hui Chang

Unternehmen	Position	Beginn
FORMOSA OPTICAL TECHNOLOGY CO.,LTD.	Director of Finance/CFO	06.11.1995
POLYLITE TAIWAN CO., LTD.	Director/Board Member	01.06.2006
Essilor Amera Pte Ltd. Essilor Amera Pte Ltd. Medical SpecialtiesHealth Technology Part of EssilorLuxottica SA, Essilor Amera Pte Ltd. is a Singaporean company that specializes in vision-related products and services. The private company is based in Singapore, Singapore. The company's flagship product, Myopilux, is an all-in-one treatment for children's myopia that has been proven to reduce myopia evolution by up to 62%%. The company also offers Transitions lenses that adapt to any light condition, as well as a range of prescription lenses for glasses.	Director/Board Member	-

Alle aktiven Positionen von Li Hui Chang

Ausbildung von Li Hui Chang

Fu Jen Catholic University

Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Li Hui Chang im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen	2
FORMOSA OPTICAL TECHNOLOGY CO.,LTD.	Health Technology
POLYLITE TAIWAN CO., LTD.	Process Industries

Private Unternehmen	1
Essilor Amera Pte Ltd. Essilor Amera Pte Ltd. Medical SpecialtiesHealth Technology Part of EssilorLuxottica SA, Essilor Amera Pte Ltd. is a Singaporean company that specializes in vision-related products and services. The private company is based in Singapore, Singapore. The company's flagship product, Myopilux, is an all-in-one treatment for children's myopia that has been proven to reduce myopia evolution by up to 62%%. The company also offers Transitions lenses that adapt to any light condition, as well as a range of prescription lenses for glasses.	Health Technology